Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-07-15 1:17 pm Purchase |
2024-07-11 | 13G | Elevation Oncology, Inc. ELEV |
Frazier Life Sciences Public Fund, L.P. | 5,993,579 11.000% |
3,035,000 (+102.58%) |
Filing History |
| 2024-04-09 4:26 pm Purchase |
2024-04-02 | 13G | Elevation Oncology, Inc. ELEV |
Frazier Life Sciences Public Fund, L.P. | 2,958,579 6.100% |
2,958,579 (New Position) |
Filing History |
| 2024-02-14 6:42 pm Purchase |
2023-12-31 | 13G | Elevation Oncology, Inc. ELEV |
ORBIMED ADVISORS LLC | 3,000,000 6.800% |
3,000,000 (New Position) |
Filing History |
| 2024-02-14 4:45 pm Purchase |
2023-12-31 | 13G | Elevation Oncology, Inc. ELEV |
K2 HealthVentures Equity Trust LLC | 1,784,169 4.000% |
217,705 (+13.90%) |
Filing History |
| 2024-02-14 4:10 pm Purchase |
2023-12-31 | 13G | Elevation Oncology, Inc. ELEV |
Point72 Asset Management, L.P. | 4,040,000 9.400% |
1,918,830 (+90.46%) |
Filing History |
| 2024-02-14 4:00 pm Purchase |
2023-12-31 | 13G | Elevation Oncology, Inc. ELEV |
TANG CAPITAL PARTNERS LP | 4,300,454 9.990% |
2,944,628 (+217.18%) |
Filing History |
| 2024-02-14 3:02 pm Sale |
2023-12-31 | 13G | Elevation Oncology, Inc. ELEV |
Cormorant Asset Management LP | 0 0.000% |
-1,952,032 (Position Closed) |
Filing History |
| 2024-02-14 10:01 am Purchase |
2023-12-31 | 13G | Elevation Oncology, Inc. ELEV |
BIOTECHNOLOGY VALUE FUND L P | 4,450,885 9.990% |
2,138,685 (+92.50%) |
Filing History |
| 2024-02-07 4:05 pm Sale |
2023-12-31 | 13G | Elevation Oncology, Inc. ELEV |
ExodusPoint Capital Management LP | 50,000 0.100% |
-1,364,824 (-96.47%) |
Filing History |
| 2024-02-06 4:15 pm Purchase |
2023-12-31 | 13G | Elevation Oncology, Inc. ELEV |
Aisling Capital IV LP | 2,878,296 6.800% |
1,735 (+0.06%) |
Filing History |
| 2024-01-31 4:32 pm Purchase |
2023-12-31 | 13G | Elevation Oncology, Inc. ELEV |
Integrated Core Strategies (US) LLC | 2,990,279 7.100% |
1,592,897 (+113.99%) |
Filing History |
| 2024-01-22 4:57 pm Purchase |
2024-01-10 | 13G | Elevation Oncology, Inc. ELEV |
Logos Global Management LP | 3,650,000 8.600% |
3,650,000 (New Position) |
Filing History |
| 2024-01-22 09:02 am Purchase |
2024-01-12 | 13G | Elevation Oncology, Inc. ELEV |
FARALLON CAPITAL PARTNERS LP | 3,100,000 7.300% |
3,100,000 (New Position) |
Filing History |
| 2024-01-09 4:24 pm Sale |
2024-01-05 | 13G | Elevation Oncology, Inc. ELEV |
Qiming U.S. Healthcare GP II LLC | 0 0.000% |
-2,370,142 (Position Closed) |
Filing History |
| 2024-01-09 09:07 am Purchase |
2023-12-31 | 13G | Elevation Oncology, Inc. ELEV |
Empery Asset Management, LP | 4,000,000 6.700% |
4,000,000 (New Position) |
Filing History |
| 2023-06-15 4:30 pm Purchase |
2023-06-13 | 13D | Elevation Oncology, Inc. ELEV |
venBio Global Strategic Fund III L.P. | 2,537,771 6.100% |
671,432 (+35.98%) |
Filing History |
| 2023-06-09 4:15 pm Purchase |
2023-06-05 | 13G | Elevation Oncology, Inc. ELEV |
ExodusPoint Capital Management LP | 1,414,824 5.800% |
1,414,824 (New Position) |
Filing History |
| 2023-06-08 4:30 pm Purchase |
2023-06-06 | 13G | Elevation Oncology, Inc. ELEV |
Integrated Core Strategies (US) LLC | 1,397,382 5.700% |
1,397,382 (New Position) |
Filing History |
| 2023-05-24 5:15 pm Purchase |
2023-05-17 | 13G | Elevation Oncology, Inc. ELEV |
Point72 Asset Management, L.P. | 2,121,170 8.700% |
2,121,170 (New Position) |
Filing History |
| 2023-02-24 4:00 pm Purchase |
2023-02-14 | 13G | Elevation Oncology, Inc. ELEV |
TANG CAPITAL PARTNERS LP | 1,355,826 5.800% |
1,355,826 (New Position) |
Filing History |